Back
Y-mAbs Therapeutics Stock Predictions
Sleep well at night with 7 stellar stocks to buy and hold forever
Get the complete list FREE for a limited time.
Sell
42
YMAB
Y-mAbs Therapeutics
Last Price:
$4.62
Seasonality Move:
7.09%
7 Day Trial
ALL ACCESS PASS
$
7
7 Stocks to Buy and Hold Forever
The result is a select group of high-quality blue-chip stocks.Y-mAbs Therapeutics Stock Forecast
-
Is Y-mAbs Therapeutics Stock Undervalued?The current Y-mAbs Therapeutics [YMAB] share price is $4.93. The Score for YMAB is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
-
YMAB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Y-mAbs Therapeutics Stock Go Up Next Year?
Data Unavailable
Y-mAbs Therapeutics Stock Rating
Data Unavailable
Y-mAbs Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
ymabs.com
52-Week Data
52-Week High:
16.11
52-Week Low:
3.55
Prediction Charts
Market Cap:
223.3M
Price in USD:
4.93
Volume:
153.7K
Beta:
0.83
Technical Analysis
SMA50:
4.44
SMA100:
5.01
SMA200:
8.62
52-Wk Change:
-58.95%
Stock Predictions
-
Is Y-mAbs Therapeutics stock public?Yes, Y-mAbs Therapeutics is a publicly traded company.
-
What is the Y-mAbs Therapeutics stock quote today?The Y-mAbs Therapeutics stock price is 4.93 USD today.
-
How to buy Y-mAbs Therapeutics stock online?You can buy Y-mAbs Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| May-23 | 4.01 | 4.32 | 4.33 | 4.00 |
| May-27 | 4.39 | 4.41 | 4.45 | 4.22 |
| May-28 | 4.62 | 4.62 | 4.74 | 4.35 |
| May-29 | 4.62 | 4.75 | 5.00 | 4.55 |
| May-30 | 4.70 | 4.60 | 4.75 | 4.49 |
| Jun-2 | 4.55 | 4.74 | 4.92 | 4.55 |
| Jun-3 | 4.78 | 4.87 | 4.96 | 4.69 |
| Jun-4 | 4.80 | 4.96 | 5.16 | 4.80 |
| Jun-5 | 4.97 | 5.10 | 5.12 | 4.75 |
| Jun-6 | 5.18 | 5.27 | 5.41 | 5.14 |
| Jun-9 | 5.36 | 5.08 | 5.47 | 5.03 |
| Jun-10 | 5.13 | 5.11 | 5.29 | 5.04 |
| Jun-11 | 5.17 | 4.93 | 5.19 | 4.91 |
| Jun-12 | 4.90 | 4.63 | 4.92 | 4.59 |
Y-mAbs Therapeutics Earnings
Data Unavailable
Y-mAbs Therapeutics Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.04 per share, a decrease this year of $0.34 per share, and a decrease next year of $0.09 per share.
* Y-mAbs Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.